Plasmodium Immunotherapy for Lung Cancer
NCT02786589
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer, Nonsmall Cell
Interventions
BIOLOGICAL:
Blood-stage infection of P. vivax
Sponsor
State Key Laboratory of Respiratory Disease
Collaborators
[object Object]